{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:37:41Z","timestamp":1792427861308,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Since the COVID-19 emergence as a global pandemic in March 2020, more than 5 million SARS-CoV-2-related deaths have been globally documented. As the pandemic progressed, it became clear that, although the infection is mainly characterized as a respiratory disease, it also affects other organs and systems, including the thyroid gland. Indeed, emerging evidence suggests that SARS-CoV-2 can act as a trigger for various thyroid disorders, for example, subacute thyroiditis (SAT), Grave\u2019s disease, and non-thyroidal illness syndrome. The entry of SARS-CoV-2 into the host cells is mainly mediated by the ACE2-receptor, making organs and systems with high expression of this receptor, such as the thyroid gland, highly vulnerable to COVID-19. Accumulating data propose that SAT may be an underestimated manifestation of COVID-19 infection. Importantly, if SAT remains unrecognized, it may trigger or aggravate potential other complications of the disease, for example, respiratory insufficiency and cardiovascular complications, and thus negatively influence prognosis. Moreover, recent case reports, case series, and systematic reviews highlight SAT as a potential side effect of the vaccination against SARS-CoV-2. The present review aims to raise awareness of SARS-CoV-2-associated- and post-vaccination subacute thyroiditis, to discuss recent evidence regarding its pathophysiology, and to present useful information for this special form of SAT related to daily clinical practice.<\/jats:p>","DOI":"10.1186\/s12985-023-02103-1","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T04:19:20Z","timestamp":1687321160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine"],"prefix":"10.1186","volume":"20","author":[{"given":"Mairi","family":"Ziaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristomenis","family":"Exadaktylos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"issue":"9","key":"2103_CR1","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s40618-021-01554-z","volume":"44","author":"G Lisco","year":"2021","unstructured":"Lisco G, et al. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. J Endocrinol Investig. 2021;44(9):1801\u201314.","journal-title":"J Endocrinol Investig"},{"key":"2103_CR2","doi-asserted-by":"crossref","unstructured":"Duntas LH, Jonklaas J. COVID-19 and thyroid diseases: a bidirectional impact. J Endocr Soc 2021;5(8): p. bvab076.","DOI":"10.1210\/jendso\/bvab076"},{"key":"2103_CR3","unstructured":"Organization WH. WHO COVID-19 dashboard. 2022."},{"issue":"6","key":"2103_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000511872","volume":"9","author":"A Khatri","year":"2021","unstructured":"Khatri A, Charlap E, Kim A. Subacute thyroiditis from COVID-19 infection: a case report and review of literature. Eur Thyroid J. 2021;9(6):324\u20138.","journal-title":"Eur Thyroid J"},{"key":"2103_CR5","doi-asserted-by":"publisher","first-page":"1041676","DOI":"10.3389\/fendo.2022.1041676","volume":"13","author":"CL Rossetti","year":"2022","unstructured":"Rossetti CL, et al. COVID-19 and thyroid function: What do we know so far? Front Endocrinol (Lausanne). 2022;13:1041676.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2103_CR6","doi-asserted-by":"crossref","unstructured":"Popescu M, et al. The new entity of subacute thyroiditis amid the COVID-19 pandemic: from infection to vaccine. Diagnostics (Basel) 2022;12(4).","DOI":"10.3390\/diagnostics12040960"},{"key":"2103_CR7","doi-asserted-by":"crossref","unstructured":"Chen W, et al. Potential interaction between SARS-CoV-2 and thyroid: a review. Endocrinology, 2021;162(3).","DOI":"10.1210\/endocr\/bqab004"},{"issue":"1","key":"2103_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jacbts.2020.11.014","volume":"6","author":"RS Ross","year":"2021","unstructured":"Ross RS. Integrating integrins: A new way to increase our COVID-19 armamentarium? JACC Basic Transl Sci. 2021;6(1):9\u201311.","journal-title":"JACC Basic Transl Sci"},{"key":"2103_CR9","doi-asserted-by":"crossref","unstructured":"Stasiak M, et al. Subacute thyroiditis is associated with HLA-B*18:01, -DRB1*01 and -C*04:01-the significance of the new molecular background. J Clin Med 2020;9(2).","DOI":"10.3390\/jcm9020534"},{"issue":"4","key":"2103_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11154-020-09615-z","volume":"22","author":"L Scappaticcio","year":"2021","unstructured":"Scappaticcio L, et al. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2021;22(4):803\u201315.","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"2103_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1399-0039.1975.tb00622.x","volume":"6","author":"S Nyulassy","year":"1975","unstructured":"Nyulassy S, Hnilica P, Stefanovic J. The HL-A system and subacute thyroiditis A preliminary report. Tissue Antigens. 1975;6(2):105\u20136.","journal-title":"Tissue Antigens"},{"issue":"2","key":"2103_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1210\/jcem-45-2-270","volume":"45","author":"S Nyulassy","year":"1977","unstructured":"Nyulassy S, et al. Subacute (de Quervain\u2019s) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins. J Clin Endocrinol Metab. 1977;45(2):270\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"2103_CR13","doi-asserted-by":"crossref","unstructured":"Stasiak M, et al. The risk of recurrence of subacute thyroiditis is HLA-dependent. Int J Mol Sci 2019;20(5).","DOI":"10.3390\/ijms20051089"},{"key":"2103_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.707726","volume":"12","author":"P Trimboli","year":"2021","unstructured":"Trimboli P, et al. COVID-19-associated subacute thyroiditis: evidence-based data from a systematic review. Front Endocrinol (Lausanne). 2021;12: 707726.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2103_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/imj.15432","volume":"52","author":"J Christensen","year":"2022","unstructured":"Christensen J, et al. Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review. Intern Med J. 2022;52(4):522\u20139.","journal-title":"Intern Med J"},{"issue":"5","key":"2103_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s40618-021-01506-7","volume":"44","author":"L Croce","year":"2021","unstructured":"Croce L, et al. The cytokine storm and thyroid hormone changes in COVID-19. J Endocrinol Investig. 2021;44(5):891\u2013904.","journal-title":"J Endocrinol Investig"},{"issue":"9","key":"2103_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-8587(20)30266-7","volume":"8","author":"I Muller","year":"2020","unstructured":"Muller I, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8(9):739\u201341.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2103_CR18","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.2147\/IJGM.S366784","volume":"15","author":"I Ray","year":"2022","unstructured":"Ray I, et al. Management of subacute thyroiditis\u2014a systematic review of current treatment protocols. Int J Gen Med. 2022;15:6425\u201339.","journal-title":"Int J Gen Med"},{"key":"2103_CR19","doi-asserted-by":"crossref","unstructured":"Olivieri B, Betterle C, Zanoni G. Vaccinations and autoimmune diseases. Vaccines (Basel) 2021;9(8).","DOI":"10.3390\/vaccines9080815"},{"key":"2103_CR20","unstructured":"Hernan Martinez J, et al. Subacute thyroiditis and dyserythropoesis after influenza vaccination suggesting immune dysregulation. Bol Asoc Med P R 2011;103(2):48\u201352."},{"issue":"1","key":"2103_CR21","first-page":"135","volume":"45","author":"J Toft","year":"1998","unstructured":"Toft J, Larsen S, Toft H. Subacute thyroiditis after hepatitis B vaccination. Endocr J. 1998;45(1):135.","journal-title":"Endocr J"},{"issue":"1\u20132","key":"2103_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12026-014-8567-3","volume":"61","author":"P Pellegrino","year":"2015","unstructured":"Pellegrino P, et al. The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems. Immunol Res. 2015;61(1\u20132):90\u20136.","journal-title":"Immunol Res"},{"issue":"1","key":"2103_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40119-021-00248-0","volume":"11","author":"AA Shiravi","year":"2022","unstructured":"Shiravi AA, et al. Cardiovascular complications of SARS-CoV-2 vaccines: an overview. Cardiol Ther. 2022;11(1):13\u201321.","journal-title":"Cardiol Ther"},{"issue":"27","key":"2103_CR24","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"8","key":"2103_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.eimc.2021.10.015","volume":"40","author":"A Flores Rebollar","year":"2022","unstructured":"Flores Rebollar A. Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine. Enferm Infecc Microbiol Clin (Engl Ed). 2022;40(8):459\u201360.","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"2103_CR26","doi-asserted-by":"crossref","unstructured":"Murashita M, et al. Subacute thyroiditis associated with thyrotoxic periodic paralysis after COVID-19 vaccination: a case report. Endocrinol Diabetes Metab Case Rep 2022;2022.","DOI":"10.1530\/EDM-22-0236"},{"issue":"12","key":"2103_CR27","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1080\/21645515.2021.2013083","volume":"17","author":"M Sozen","year":"2021","unstructured":"Sozen M, et al. COVID-19 mRNA vaccine may trigger subacute thyroiditis. Hum Vaccin Immunother. 2021;17(12):5120\u20135.","journal-title":"Hum Vaccin Immunother"},{"key":"2103_CR28","doi-asserted-by":"crossref","unstructured":"Khan F, Brassill MJ. Subacute thyroiditis post-Pfizer-BioNTech mRNA vaccination for COVID-19. Endocrinol Diabetes Metab Case Rep 2021;2021.","DOI":"10.1530\/EDM-21-0142"},{"key":"2103_CR29","first-page":"7604295","volume":"2022","author":"A Saha","year":"2022","unstructured":"Saha A, Chittimoju S, Trivedi N. Thyroiditis after mRNA vaccination for COVID-19. Case Rep Endocrinol. 2022;2022:7604295.","journal-title":"Case Rep Endocrinol"},{"issue":"6","key":"2103_CR30","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e39","volume":"37","author":"M Jhon","year":"2022","unstructured":"Jhon M, et al. Subacute thyroiditis after receiving the mRNA COVID-19 vaccine (Moderna): the first case report and literature review in Korea. J Korean Med Sci. 2022;37(6): e39.","journal-title":"J Korean Med Sci"},{"issue":"6","key":"2103_CR31","volume":"13","author":"SO Oyibo","year":"2021","unstructured":"Oyibo SO. Subacute thyroiditis after receiving the adenovirus-vectored vaccine for coronavirus disease (COVID-19). Cureus. 2021;13(6): e16045.","journal-title":"Cureus"},{"issue":"2","key":"2103_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.55729\/2000-9666.1033","volume":"12","author":"S Raashid","year":"2022","unstructured":"Raashid S, et al. Subacute thyroiditis after receiving inactivated virus vaccine for COVID-19. J Community Hosp Intern Med Perspect. 2022;12(2):14\u20137.","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2103_CR33","doi-asserted-by":"crossref","unstructured":"Gonzalez Lopez J, Martin Nino I, Arana Molina C. Subacute thyroiditis after SARS-CoV-2 vaccination: report of two clinical cases. Med Clin (Engl Ed) 2022;158(12):e13\u2013e14.","DOI":"10.1016\/j.medcle.2022.05.007"},{"key":"2103_CR34","doi-asserted-by":"crossref","unstructured":"Sahin Tekin M, Saylisoy S, Yorulmaz G. Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report. Hum Vaccin Immunother 2021;17(11):4090\u20134092.","DOI":"10.1080\/21645515.2021.1947102"},{"issue":"9","key":"2103_CR35","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1210\/clinem\/dgab373","volume":"106","author":"BG Iremli","year":"2021","unstructured":"Iremli BG, Sendur SN, Unluturk U. Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. J Clin Endocrinol Metab. 2021;106(9):2600\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"2103_CR36","first-page":"3180004","volume":"2022","author":"J Adelmeyer","year":"2022","unstructured":"Adelmeyer J, et al. Two case reports of subacute thyroiditis after receiving vaccine for COVID-19. Case Rep Endocrinol. 2022;2022:3180004.","journal-title":"Case Rep Endocrinol"},{"issue":"2","key":"2103_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.7774\/cevr.2022.11.2.226","volume":"11","author":"TB Vu","year":"2022","unstructured":"Vu TB, et al. Subacute thyroiditis after receiving the vaccine for COVID-19: a case report and literature review. Clin Exp Vaccine Res. 2022;11(2):226\u20139.","journal-title":"Clin Exp Vaccine Res"},{"issue":"1","key":"2103_CR38","volume":"10","author":"K Ie","year":"2023","unstructured":"Ie K, et al. Subacute thyroiditis developing within 2 days of vaccination against COVID-19 with BNT162b2 mRNA. Eur J Case Rep Intern Med. 2023;10(1): 003735.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"4","key":"2103_CR39","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s40618-021-01718-x","volume":"45","author":"AB Bahcecioglu","year":"2022","unstructured":"Bahcecioglu AB, et al. Subacute thyroiditis during the COVID-19 pandemic: a prospective study. J Endocrinol Investig. 2022;45(4):865\u201374.","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"2103_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s42000-021-00332-z","volume":"21","author":"S Chatzi","year":"2022","unstructured":"Chatzi S, et al. Subacute thyroiditis after SARS-CoV-2 vaccination: a report of two sisters and summary of the literature. Hormones (Athens). 2022;21(1):177\u20139.","journal-title":"Hormones (Athens)"},{"issue":"2","key":"2103_CR41","first-page":"210","volume":"25","author":"S Frangos","year":"2022","unstructured":"Frangos S, et al. Subacute thyroiditis after the third dose of the COVID-19 mRNA vaccine. Case report Hell J Nucl Med. 2022;25(2):210\u20132.","journal-title":"Case report Hell J Nucl Med"},{"key":"2103_CR42","doi-asserted-by":"crossref","unstructured":"Casey C, Higgins T. Subacute thyroiditis post viral vector vaccine for COVID-19. Endocrinol Diabetes Metab Case Rep 2022;2022.","DOI":"10.1530\/EDM-21-0193"},{"issue":"8","key":"2103_CR43","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1507\/endocrj.EJ21-0629","volume":"69","author":"M Kishimoto","year":"2022","unstructured":"Kishimoto M, Ishikawa T, Odawara M. Subacute thyroiditis with liver dysfunction following coronavirus disease 2019 (COVID-19) vaccination: report of two cases and a literature review. Endocr J. 2022;69(8):947\u201357.","journal-title":"Endocr J"},{"issue":"10","key":"2103_CR44","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zhao B, Liang YB. Successful treatment of subacute thyroiditis after recombinant COVID-19 vaccination using traditional chinese medicine: a case report. Cureus. 2022;14(10): e30716.","journal-title":"Cureus"},{"issue":"2","key":"2103_CR45","volume":"14","author":"M Borges Canha","year":"2022","unstructured":"Borges Canha M, et al. Subacute thyroiditis after severe acute respiratory syndrome coronavirus 2 Vaxzevria vaccination in a patient with thyroid autoimmunity. Cureus. 2022;14(2): e22353.","journal-title":"Cureus"},{"issue":"4","key":"2103_CR46","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s40618-021-01707-0","volume":"45","author":"A Pujol","year":"2022","unstructured":"Pujol A, et al. Thyroid as a target of adjuvant autoimmunity\/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves\u2019 disease to silent thyroiditis. J Endocrinol Invest. 2022;45(4):875\u201382.","journal-title":"J Endocrinol Invest"},{"key":"2103_CR47","doi-asserted-by":"crossref","unstructured":"Saygili ES, Karakilic E. Subacute thyroiditis after inactive SARS-CoV-2 vaccine. BMJ Case Rep 2021;14(10).","DOI":"10.1136\/bcr-2021-244711"},{"issue":"4","key":"2103_CR48","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ando.2022.04.014","volume":"83","author":"F Bres","year":"2022","unstructured":"Bres F, et al. Three cases of thyroiditis after COVID-19 RNA-vaccine. Ann Endocrinol (Paris). 2022;83(4):262\u20134.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"3","key":"2103_CR49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.aace.2021.12.002","volume":"8","author":"M Pandya","year":"2022","unstructured":"Pandya M, et al. Thyroiditis after COVID-19 mRNA vaccine: a case series. AACE Clin Case Rep. 2022;8(3):116\u20138.","journal-title":"AACE Clin Case Rep"},{"key":"2103_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2021.100136","volume":"12","author":"A Siolos","year":"2021","unstructured":"Siolos A, Gartzonika K, Tigas S. Thyroiditis following vaccination against COVID-19: Report of two cases and review of the literature. Metabol Open. 2021;12: 100136.","journal-title":"Metabol Open"},{"issue":"5","key":"2103_CR51","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s40618-022-01739-0","volume":"45","author":"B PlaPeris","year":"2022","unstructured":"PlaPeris B, et al. Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion. J Endocrinol Investig. 2022;45(5):1071\u20137.","journal-title":"J Endocrinol Investig"},{"key":"2103_CR52","doi-asserted-by":"crossref","unstructured":"Alkis N, Baysal M. Subacute thyroiditis after SARS-CoV-2 BNT162b2 vaccine in a multiple myeloma patient. SAGE Open Med Case Rep 2022;10:2050313X221091392.","DOI":"10.1177\/2050313X221091392"},{"issue":"10","key":"2103_CR53","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s40618-022-01856-w","volume":"45","author":"C Teti","year":"2022","unstructured":"Teti C, et al. Subacute thyroiditis after SARS-CoV2 vaccine: possible relapse after boosting. J Endocrinol Invest. 2022;45(10):2019\u201320.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2103_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2021.103211","volume":"43","author":"KR Patel","year":"2022","unstructured":"Patel KR, Cunnane ME, Deschler DG. SARS-CoV-2 vaccine-induced subacute thyroiditis. Am J Otolaryngol. 2022;43(1): 103211.","journal-title":"Am J Otolaryngol"},{"key":"2103_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.737142","volume":"8","author":"C Bornemann","year":"2021","unstructured":"Bornemann C, Woyk K, Bouter C. Case report: two cases of subacute thyroiditis following SARS-CoV-2 vaccination. Front Med (Lausanne). 2021;8: 737142.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"2103_CR56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/cen.14555","volume":"97","author":"GM Ratnayake","year":"2022","unstructured":"Ratnayake GM, Dworakowska D, Grossman AB. Can COVID-19 immunisation cause subacute thyroiditis? Clin Endocrinol (Oxf). 2022;97(1):140\u20131.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2103_CR57","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s40618-021-01681-7","volume":"45","author":"L Das","year":"2022","unstructured":"Das L, Bhadada SK, Sood A. Post-COVID-vaccine autoimmune\/inflammatory syndrome in response to adjuvants (ASIA syndrome) manifesting as subacute thyroiditis. J Endocrinol Invest. 2022;45(2):465\u20137.","journal-title":"J Endocrinol Invest"},{"key":"2103_CR58","doi-asserted-by":"crossref","unstructured":"Jeeyavudeen MS, et al. COVID-19 vaccine-associated subacute thyroiditis: an unusual suspect for de Quervain's thyroiditis. BMJ Case Rep 2021;14(11).","DOI":"10.1136\/bcr-2021-246425"},{"key":"2103_CR59","first-page":"8952048","volume":"2021","author":"L Plaza-Enriquez","year":"2021","unstructured":"Plaza-Enriquez L, et al. A case report of subacute thyroiditis following mRNA COVID-19 vaccine. Case Rep Endocrinol. 2021;2021:8952048.","journal-title":"Case Rep Endocrinol"},{"key":"2103_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.crwh.2021.e00378","volume":"33","author":"V Vasileiou","year":"2022","unstructured":"Vasileiou V, et al. Recurring subacute thyroiditis after SARS-CoV-2 mRNA vaccine: a case report. Case Rep Womens Health. 2022;33: e00378.","journal-title":"Case Rep Womens Health"},{"issue":"3","key":"2103_CR61","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s42000-022-00380-z","volume":"21","author":"H Bostan","year":"2022","unstructured":"Bostan H, et al. Evaluation of the diagnostic features and clinical course of COVID-19 vaccine-associated subacute thyroiditis. Hormones (Athens). 2022;21(3):447\u201355.","journal-title":"Hormones (Athens)"},{"key":"2103_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.918721","volume":"9","author":"L Pi","year":"2022","unstructured":"Pi L, et al. Case Report: Subacute thyroiditis after receiving inactivated SARS-CoV-2 vaccine (BBIBP-CorV). Front Med (Lausanne). 2022;9: 918721.","journal-title":"Front Med (Lausanne)"},{"key":"2103_CR63","doi-asserted-by":"crossref","unstructured":"Wijenayake UN, et al. A case report of subacute thyroiditis after inactivated SARS-CoV-2 vaccine. SAGE Open Med Case Rep 2022;10:2050313X221140243.","DOI":"10.1177\/2050313X221140243"},{"key":"2103_CR64","doi-asserted-by":"crossref","unstructured":"Yorulmaz G, Sahin Tekin M. SARS-CoV-2 vaccine-associated subacute thyroiditis. J Endocrinol Investig 2022;45(7):1341\u20131347.","DOI":"10.1007\/s40618-022-01767-w"},{"issue":"1","key":"2103_CR65","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/idr14010018","volume":"14","author":"G Pipitone","year":"2022","unstructured":"Pipitone G, et al. Vaccine-induced subacute thyroiditis (De Quervain\u2019s) after mRNA vaccine against SARS-CoV-2: a case report and systematic review. Infect Dis Rep. 2022;14(1):142\u201354.","journal-title":"Infect Dis Rep"},{"key":"2103_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.856572","volume":"9","author":"Y Huang","year":"2022","unstructured":"Huang Y, et al. Case report: subacute thyroiditis after receiving SARS-CoV-2 vaccine, maybe not only adjuvants. Front Med (Lausanne). 2022;9: 856572.","journal-title":"Front Med (Lausanne)"},{"key":"2103_CR67","doi-asserted-by":"crossref","unstructured":"Stasiak M, Zawadzka-Starczewska K, Lewinski A. Significance of HLA haplotypes in two patients with subacute thyroiditis triggered by mRNA-based COVID-19 vaccine. Vaccines (Basel) 2022;10(2).","DOI":"10.3390\/vaccines10020280"},{"issue":"6","key":"2103_CR68","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1055\/a-1840-4374","volume":"54","author":"O Topaloglu","year":"2022","unstructured":"Topaloglu O, et al. Differences in clinical aspects between subacute thyroiditis associated with COVID-19 vaccines and classical subacute thyroiditis. Horm Metab Res. 2022;54(6):380\u20138.","journal-title":"Horm Metab Res"},{"issue":"10","key":"2103_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4812","volume":"9","author":"P Soltanpoor","year":"2021","unstructured":"Soltanpoor P, Norouzi G. Subacute thyroiditis following COVID-19 vaccination. Clin Case Rep. 2021;9(10): e04812.","journal-title":"Clin Case Rep"},{"key":"2103_CR70","volume":"26","author":"V Reisi-Vanani","year":"2022","unstructured":"Reisi-Vanani V, et al. Role of the immune system and possible mechanisms in COVID-19 vaccine-induced thyroiditis: Case report and literature review. J Clin Transl Endocrinol Case Rep. 2022;26: 100138.","journal-title":"J Clin Transl Endocrinol Case Rep"},{"key":"2103_CR71","unstructured":"Sigstad E, Groholt KK Westerheim O. Subacute thyroiditis after vaccination against SARS-CoV-2. Tidsskr Nor Laegeforen 2021;141(2021\u201314)."},{"issue":"5","key":"2103_CR72","doi-asserted-by":"publisher","first-page":"e1823","DOI":"10.1210\/clinem\/dgac049","volume":"107","author":"SH Oguz","year":"2022","unstructured":"Oguz SH, et al. SARS-CoV-2 vaccine-induced thyroiditis: safety of revaccinations and clinical follow-up. J Clin Endocrinol Metab. 2022;107(5):e1823\u201334.","journal-title":"J Clin Endocrinol Metab"},{"key":"2103_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108480","volume":"217","author":"A Vojdani","year":"2020","unstructured":"Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217: 108480.","journal-title":"Clin Immunol"},{"key":"2103_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.617089","volume":"11","author":"A Vojdani","year":"2020","unstructured":"Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2020;11: 617089.","journal-title":"Front Immunol"},{"key":"2103_CR75","first-page":"150","volume":"7","author":"A Watad","year":"2016","unstructured":"Watad A, et al. Autoimmune\/inflammatory syndrome induced by adjuvants and thyroid autoimmunity. Front Endocrinol (Lausanne). 2016;7:150.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2103_CR76","doi-asserted-by":"publisher","first-page":"107602962110208","DOI":"10.1177\/10760296211020833","volume":"27","author":"B Joob","year":"2021","unstructured":"Joob B, Wiwanitkit V. Expected viscosity after COVID-19 vaccination, hyperviscosity and previous COVID-19. Clin Appl Thromb Hemost. 2021;27:10760296211020832.","journal-title":"Clin Appl Thromb Hemost"},{"key":"2103_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.900964","volume":"13","author":"V Caironi","year":"2022","unstructured":"Caironi V, Pitoia F, Trimboli P. Thyroid inconveniences with vaccination against SARS-CoV-2: the size of the matter a systematic review. Front Endocrinol (Lausanne). 2022;13: 900964.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2103_CR78","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2002-021799","volume":"88","author":"V Fatourechi","year":"2003","unstructured":"Fatourechi V, et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab. 2003;88(5):2100\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2103_CR79","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s40618-022-01786-7","volume":"45","author":"A Jafarzadeh","year":"2022","unstructured":"Jafarzadeh A, et al. Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence. J Endocrinol Investig. 2022;45(10):1835\u201363.","journal-title":"J Endocrinol Investig"},{"key":"2103_CR80","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejim.2021.10.008","volume":"94","author":"A Kyriacou","year":"2021","unstructured":"Kyriacou A, Ioakim S, Syed AA. COVID-19 vaccination and a severe pain in the neck. Eur J Intern Med. 2021;94:95\u20136.","journal-title":"Eur J Intern Med"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-02103-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-023-02103-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-02103-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T05:06:06Z","timestamp":1687323966000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-023-02103-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2103"],"URL":"https:\/\/doi.org\/10.1186\/s12985-023-02103-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"assertion":[{"value":"15 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}